(Q38005217)

26 August 2017

title

IL-33 and HMGB1 alarmins: sensors of cellular death and their involvement in liver pathology (English)

1 reference

26 August 2017

0 references

Muhammad I Arshad

1

1 reference

26 August 2017

Claire Piquet-Pellorce

series ordinal

2

1 reference

26 August 2017

Michel Samson

series ordinal

3

1 reference

26 August 2017

publication date

24 April 2012

1 reference

26 August 2017

1 reference

26 August 2017

volume

32

1 reference

26 August 2017

issue

8

1 reference

26 August 2017

page(s)

1200-1210

1 reference

Alarmins: chemotactic activators of immune responses

26 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2012.02802.X

DAMPs, PAMPs and alarmins: all we need to know about danger

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2012.02802.X

Interleukin-33 - cytokine of dual function or novel alarmin?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2012.02802.X

The IL-1-like cytokine IL-33 is constitutively expressed in the nucleus of endothelial cells and epithelial cells in vivo: a novel 'alarmin'?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2012.02802.X

IL-33 and ST2 comprise a critical biomechanically induced and cardioprotective signaling system

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2012.02802.X

NKT cells are required to induce high IL-33 expression in hepatocytes during ConA-induced acute hepatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2012.02802.X

IL-33, the IL-1-like cytokine ligand for ST2 receptor, is a chromatin-associated nuclear factor in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2012.02802.X

Interleukin-33 overexpression is associated with liver fibrosis in mice and humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2012.02802.X

IL-33 reduces the development of atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2012.02802.X

Serum levels of IL-33 and soluble ST2 and their association with disease activity in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2012.02802.X

Increased expression of IL-33 in severe asthma: evidence of expression by airway smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2012.02802.X

IL-33 exacerbates antigen-induced arthritis by activating mast cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2012.02802.X

High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2012.02802.X

Hepatoma-derived growth factor is a neurotrophic factor harbored in the nucleus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2012.02802.X

The expression of HMGB1 protein and its receptor RAGE in human malignant tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2012.02802.X

The nuclear protein HMGB1 is secreted by monocytes via a non-classical, vesicle-mediated secretory pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2012.02802.X

Bacterial endotoxin stimulates macrophages to release HMGB1 partly through CD14- and TNF-dependent mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2012.02802.X

Bacterial endotoxin induces the release of high mobility group box 1 via the IFN-beta signaling pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2012.02802.X

Receptor for advanced glycation end products (RAGE)-mediated neurite outgrowth and activation of NF-kappaB require the cytoplasmic domain of the receptor but different downstream signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2012.02802.X

The receptor RAGE: Bridging inflammation and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2012.02802.X

HMGB1, a potent proinflammatory cytokine in sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2012.02802.X

Targeting HMGB1 in inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2012.02802.X

IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2012.02802.X

Molecular characterization of NF-HEV, a nuclear factor preferentially expressed in human high endothelial venules

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2012.02802.X

Role of interleukin 33 in human immunopathology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2012.02802.X

The IL-1-like cytokine IL-33 is inactivated after maturation by caspase-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2012.02802.X

Suppression of interleukin-33 bioactivity through proteolysis by apoptotic caspases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2012.02802.X

The enigmatic processing and secretion of interleukin-33.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2012.02802.X

Interleukin-33 is biologically active independently of caspase-1 cleavage

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2012.02802.X

Caspase 3 inactivates biologically active full length interleukin-33 as a classical cytokine but does not prohibit nuclear translocation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2012.02802.X

The danger signal, extracellular ATP, is a sensor for an airborne allergen and triggers IL-33 release and innate Th2-type responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2012.02802.X

The pro-Th2 cytokine IL-33 directly interacts with invariant NKT and NK cells to induce IFN-gamma production.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2012.02802.X

IL-33 and IL-33 receptors in host defense and diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2012.02802.X

The essential role of single Ig IL-1 receptor-related molecule/Toll IL-1R8 in regulation of Th2 immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2012.02802.X

Disease-associated functions of IL-33: the new kid in the IL-1 family

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2012.02802.X

The dual function cytokine IL-33 interacts with the transcription factor NF-κB to dampen NF-κB-stimulated gene transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2012.02802.X

The lack of chromosomal protein Hmg1 does not disrupt cell growth but causes lethal hypoglycaemia in newborn mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2012.02802.X

Septic shock is associated with receptor for advanced glycation end products ligation of LPS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2012.02802.X

Lack of the receptor for advanced glycation end-products attenuates E. coli pneumonia in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2012.02802.X

Soluble ST2 blocks interleukin-33 signaling in allergic airway inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2012.02802.X

Infection with influenza virus induces IL-33 in murine lungs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2012.02802.X

ST2 deficient mice display a normal host defense against pulmonary infection with Mycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2012.02802.X

ST2 deletion enhances innate and acquired immunity to murine mammary carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2012.02802.X

IL-33 is a crucial amplifier of innate rather than acquired immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2012.02802.X

Improving vaccines by incorporating immunological coadjuvants

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2012.02802.X

Interleukin-1 family cytokines as mucosal vaccine adjuvants for induction of protective immunity against influenza virus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2012.02802.X

Innate immune sensing of pathogens and danger signals by cell surface Toll-like receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2012.02802.X

Molecular adjuvant HMGB1 enhances anti-influenza immunity during DNA vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2012.02802.X

The immune-modulating cytokine and endogenous Alarmin interleukin-33 is upregulated in skin exposed to inflammatory UVB radiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2012.02802.X

Up-regulation of interleukin 33 and soluble ST2 serum levels in liver failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2012.02802.X

Advanced glycation end products induce production of reactive oxygen species via the activation of NADPH oxidase in murine hepatic stellate cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2012.02802.X

Role of the receptor for advanced glycation end products in hepatic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2012.02802.X

Specific siRNA targeting the receptor for advanced glycation end products inhibits experimental hepatic fibrosis in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2012.02802.X

A novel function of the receptor for advanced glycation end-products (RAGE) in association with tumorigenesis and tumor differentiation of HCC

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2012.02802.X

RAGE signaling significantly impacts tumorigenesis and hepatic tumor growth in murine models of colorectal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2012.02802.X

What is the role of the receptor for advanced glycation end products-ligand axis in liver injury?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2012.02802.X

The role of NKT cells in animal models of autoimmune hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2012.02802.X

Critical contribution of liver natural killer T cells to a murine model of hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2012.02802.X

HMGB1 cytoplasmic translocation in patients with acute liver failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2012.02802.X

Treatment with HMGB1 inhibitors diminishes CTL-induced liver disease in HBV transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2012.02802.X

Soluble ST2 plasma concentrations predict mortality in severe sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2012.02802.X

Serum interleukin-33 levels in patients with gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2012.02802.X

Blockade of receptor for advanced glycation end product (RAGE) attenuates ischemia and reperfusion injury to the liver in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2012.02802.X

HMG-1 as a late mediator of endotoxin lethality in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2012.02802.X

Release of chromatin protein HMGB1 by necrotic cells triggers inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2012.02802.X

HMGB1 signals through toll-like receptor (TLR) 4 and TLR2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2012.02802.X

High-mobility group box protein 1 (HMGB1): an alarmin mediating the pathogenesis of rheumatic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2012.02802.X

Endogenous interleukin 1 alpha must be transported to the nucleus to exert its activity in human endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2012.02802.X

The precursor form of IL-1alpha is an intracrine proinflammatory activator of transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2012.02802.X

Hepatocyte necrosis induced by oxidative stress and IL-1 alpha release mediate carcinogen-induced compensatory proliferation and liver tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2012.02802.X

Cryopyrin activates the inflammasome in response to toxins and ATP

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2012.02802.X

Necrotic cells trigger a sterile inflammatory response through the Nlrp3 inflammasome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2012.02802.X

ATP release guides neutrophil chemotaxis via P2Y2 and A3 receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2012.02802.X

Nucleotides released by apoptotic cells act as a find-me signal to promote phagocytic clearance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2012.02802.X

Molecular identification of a danger signal that alerts the immune system to dying cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2012.02802.X

Gout-associated uric acid crystals activate the NALP3 inflammasome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2012.02802.X

Uric acid is a danger signal activating NALP3 inflammasome in lung injury inflammation and fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2012.02802.X

Uric acid and HMGB1 are involved in the induction of autoantibodies elicited in mice infected with mouse hepatitis virus A59.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2012.02802.X

S100 proteins expressed in phagocytes: a novel group of damage-associated molecular pattern molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2012.02802.X

S100 family members and trypsinogens are predictors of distant metastasis and survival in early-stage non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2012.02802.X

Hyaluronan fragments act as an endogenous danger signal by engaging TLR2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2012.02802.X

Hyaluronan induces cell death in activated T cells through CD44.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2012.02802.X

NLRP3/cryopyrin is necessary for interleukin-1beta (IL-1beta) release in response to hyaluronan, an endogenous trigger of inflammation in response to injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2012.02802.X

Regulation of non-infectious lung injury, inflammation, and repair by the extracellular matrix glycosaminoglycan hyaluronan.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2012.02802.X

Receptor-mediated monitoring of tissue well-being via detection of soluble heparan sulfate by Toll-like receptor 4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2012.02802.X

Kupffer cells hasten resolution of liver immunopathology in mouse models of viral hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2012.02802.X

IL-33 induces skin inflammation with mast cell and neutrophil activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2012.02802.X

10.1111/J.1478-3231.2012.02802.X

21 January 2018

Identifiers

DOI

1 reference

26 August 2017

1 reference